Drug Database
A10 DRUGS USED IN DIABETES
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- A10AB01 insulin (human)
- A10AB03 insulin (pork)
- A10AB04 insulin lispro
- A10AB05 insulin aspart
- A10AB06 insulin glulisine
- A10AC01 insulin (human)
- A10AC03 insulin (pork)
- A10AD01 insulin (human)
- A10AD03 insulin (pork)
- A10AD04 insulin lispro
- A10AD05 insulin aspart
- A10AE04 insulin glargine
- A10AE05 insulin detemir
- A10AE06 insulin degludec
- A10AE54 insulin glargine and lixisenatide
- A10AE56 insulin degludec and liraglutide
- A10BA02 metformin
- A10BB01 glibenclamide
- A10BB03 tolbutamide
- A10BB07 glipizide
- A10BB09 gliclazide
- A10BB12 glimepiride
- A10BD05 metformin and pioglitazone
- A10BD07 metformin and sitagliptin
- A10BD08 metformin and vildagliptin
- A10BD10 metformin and saxagliptin
- A10BD11 metformin and linagliptin
- A10BD13 metformin and alogliptin
- A10BD15 metformin and dapagliflozin
- A10BD16 metformin and canagliflozin
- A10BD19 linagliptin and empagliflozin
- A10BD20 metformin and empagliflozin
- A10BD21 saxagliptin and dapagliflozin
- A10BF01 acarbose
- A10BG03 pioglitazone
- A10BH01 sitagliptin
- A10BH02 vildagliptin
- A10BH03 saxagliptin
- A10BH04 alogliptin
- A10BH05 linagliptin
- A10BJ01 exenatide
- A10BJ02 liraglutide
- A10BJ03 lixisenatide
- A10BJ05 dulaglutide
- A10BJ06 semaglutide
- A10BK01 dapagliflozin
- A10BK02 canagliflozin
- A10BK03 empagliflozin
- A10BK04 ertugliflozin
- A10BX02 repaglinide
- A10BX03 nateglinide
- A10BX16 tirzepatide
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).